1. Home
  2. GNLX vs ANVS Comparison

GNLX vs ANVS Comparison

Compare GNLX & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • ANVS
  • Stock Information
  • Founded
  • GNLX 2001
  • ANVS 2008
  • Country
  • GNLX United States
  • ANVS United States
  • Employees
  • GNLX N/A
  • ANVS N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • ANVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNLX Health Care
  • ANVS Health Care
  • Exchange
  • GNLX Nasdaq
  • ANVS Nasdaq
  • Market Cap
  • GNLX 85.0M
  • ANVS 92.6M
  • IPO Year
  • GNLX 2023
  • ANVS 2020
  • Fundamental
  • Price
  • GNLX $4.31
  • ANVS $2.95
  • Analyst Decision
  • GNLX Strong Buy
  • ANVS Strong Buy
  • Analyst Count
  • GNLX 4
  • ANVS 6
  • Target Price
  • GNLX $18.25
  • ANVS $29.67
  • AVG Volume (30 Days)
  • GNLX 314.9K
  • ANVS 548.9K
  • Earning Date
  • GNLX 03-31-2025
  • ANVS 03-31-2025
  • Dividend Yield
  • GNLX N/A
  • ANVS N/A
  • EPS Growth
  • GNLX N/A
  • ANVS N/A
  • EPS
  • GNLX N/A
  • ANVS N/A
  • Revenue
  • GNLX $8,000.00
  • ANVS N/A
  • Revenue This Year
  • GNLX N/A
  • ANVS N/A
  • Revenue Next Year
  • GNLX N/A
  • ANVS N/A
  • P/E Ratio
  • GNLX N/A
  • ANVS N/A
  • Revenue Growth
  • GNLX N/A
  • ANVS N/A
  • 52 Week Low
  • GNLX $1.60
  • ANVS $2.88
  • 52 Week High
  • GNLX $9.82
  • ANVS $20.00
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 75.11
  • ANVS 20.82
  • Support Level
  • GNLX $3.20
  • ANVS $2.99
  • Resistance Level
  • GNLX $4.23
  • ANVS $5.50
  • Average True Range (ATR)
  • GNLX 0.56
  • ANVS 0.34
  • MACD
  • GNLX 0.10
  • ANVS -0.18
  • Stochastic Oscillator
  • GNLX 95.73
  • ANVS 3.59

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Share on Social Networks: